BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Talks.cam//talks.cam.ac.uk//
X-WR-CALNAME:Talks.cam
BEGIN:VEVENT
SUMMARY:Developing an artificial heart - Dr Mark Goldberg - Camp Lowell Ca
 rdiology
DTSTART:20221019T140500Z
DTEND:20221019T145500Z
UID:TALK184004@talks.cam.ac.uk
CONTACT:Ben Karniely
DESCRIPTION:Abstract\n\nThe commercialization of the total artificial hear
 t by Syncardia is seen as a prime example of the successful combined appli
 cation of modern day mechanical\, electrical\, and systems engineering to 
 medicine. Straddling between engineering challenges\, regulatory issues an
 d ethical concerns\, Syncardia managed to develop and deliver a product th
 at to date has been credited with extending countless human lives.\n\nIn m
 y presentation I will give my personal perspective on this journey\, havin
 g served at Syncardia wearing multiple hats to include Chief Medical Offic
 er\, Board member and co-author of medical trials which advanced the devic
 e. I will show - in pictures and “war stories” - how we gradually refi
 ned the device from an artificial heart that required support equipment th
 e size of a filing cabinet\, into a mobile unit that allows for normal act
 ivities of daily living for many months and sometimes years – a journey 
 that started with Dr. Kolff in 1952 and saw the application of then-state-
 of-the-art engineering solutions\, modernized over time.\n\n35 years on (m
 y first contact with the artificial heart was in 1987)\, I am saddened to 
 say that medical device technology is now years behind the state-of-the-ar
 t in industrial engineering\, and the gap is widening every year. This gap
  is caused by many things\, including complex regulation\, legal aspects\,
  and ethical concerns\, but also an increasing distance between the engine
 ering departments and medical schools.\n\nThe speaker\n\nDr Mark Goldberg 
 received his medical degree from Medical College of Georgia and trained in
  internal medicine and cardiology at the University of Arizona.  \n\nIn 20
 01 Mark joined Syncardia\, maker of the first total artificial heart for u
 se in humans\, where he served on the board of directors and as Chief Medi
 cal Officer. During his time at Syncardia\, Mark was an integral part in t
 he design and execution of clinical trials which obtained FDA approval of 
 the total artificial heart (TAH) as a bridge to transplant\, miniaturizati
 on of the driver system and production of a mechanical valve for use in th
 e TAH.  He was also part of the design process for the ongoing study of us
 e of the TAH for destination therapy. \n\nIn addition to Syncardia\, Mark 
 also served as Chief Medical Officer for Micro Med Cardiovascular (manufac
 turer of a left ventricular assist device)\, and Saguro Clinical Research.
   Mark has been the principal investigator on 53 clinical research studies
 .  \nIn addition to his corporate and research engagements Mark has also p
 racticed cardiology/interventional cardiology in Tucson for the past 30 ye
 ars.\n\nMark is sponsor to technology innovation and serves on the board o
 f multiple early and mid-stage companies which have included Global Solar 
 Energy and ei3.  He continues to contribute his skills and experiences to 
 help narrow the gap between engineering and medicine\, and help bring life
 -saving technology to medical use quickly and efficiently.\n\nLink to join
  virtually: https://zoom.us/j/98901725392?pwd=UWNVZVFTcVQxL2JkS0V1WVBoelBu
 UT09\n\nA recording of this talk is available at the following link: https
 ://www.cl.cam.ac.uk/seminars/wednesday/video/\n
LOCATION:Lecture Theatre 1\, Computer Laboratory\, William Gates Building
END:VEVENT
END:VCALENDAR